Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: Difficulties at diagnosis and rational of the therapeutic strategy

Leukemia Research

Volumn 30, Issue 3, 2006, Pages 349-353

  Orciuolo, Enrico ^a   Fazzi, Rita ^a   Galimberti, Sara ^a   Testi, Cesarina ^b   Azzara', Antonio ^a   Carulli, Giovanni ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Section of Anatomia Patologica II   (Italy)

Author keywords

CML and HCL; Imatinib; Interferon; Rituximab

Indexed keywords

ALPHA2B INTERFERON; CD20 ANTIBODY; IMATINIB; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; CANCER STAGING; CANCER THERAPY; CASE REPORT; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG TOLERANCE; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LABORATORY TEST; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; PHILADELPHIA CHROMOSOME POSITIVE CELL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR BIOPSY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; INTERFERONS; LEUKEMIA, HAIRY CELL; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; NEOPLASMS, SECOND PRIMARY; PIPERAZINES; PYRIMIDINES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 30144433868     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.07.011     Document Type: Article

References (15)

1. N. Takahashi, I. Miura, K. Saitoh, and A.B. Miura Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization Blood 92 1998 4758 4763
2. R.H. Jacobs, E.E. Vokes, and H.M. Golomb Second malignancies in hairy cell leukemia Cancer 56 1985 1462 1467
3. L. Pajor, L. Kareskai, P. Tamaska, J.A. Vass, and G. Radvanyi Coexistence of chronic myeloid leukemia and hairy cell leukemia of common clonal origin Cancer Genet Cytogen 134 2002 114 117
4. J.E. Reeves, B.A. Robbins, L.R. Pankey, A.L. Elias, and W.F. Anderson The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia Cancer 75 1995 2089 2092
5. F.A. Wandroo, D. Bareford, and F. El-Jehani Chronic myeloid leukaemia occurring in a patient with hairy cell leukaemia J Clin Pathol 53 2000 940 941
6. A. Seven, C. Burian, and J.A. Kaziol Long term follow-up of patients with hairy cell leukemia following cladribine treatment Blood 92 1998 1918
7. R. Fazzi, F. Caracciolo, S. Galimberti, and M. Petrini Early reappearance of primary solid cancer in patients treated with purine analog J Chemother 15 4 2003 Aug. 406 408
8. G. Juliusson, R. Lenkei, and J. Liliemark Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocytes subset after treatment with 2-chlorodeoxyadenosine Blood 83 1994 3672
9. J. Saymour, R. Kurzrock, and E.J. Freireich 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia Blood 83 1994 2906
10. P. Kampmeier, R. Spielberger, J. Dickstein, R. Mick, H. Golomb, and J.W. Vardiman Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinopathologic assessment Blood 83 1994 2931 2938
11. The Italian Cooperative Study Group on Chronic Myeloid Leukemia Long-term follow-up of the Italian trial of interferon-α vs. conventional chemotherapy in chronic myeloid leukemia Blood 92 1998 1541
12. S. Sacchi, H.M. Kantarjian, and T.L. Smith Early treatment decision with interferon-alpha therapy in early chronic phase chronic myelogenous leukaemia J Clin Oncol 16 1998 882
13. J. Cortes, H.M. Kantarjian, and S. O'Brian Result of interferon-alpha therapy in patient with chronic myelogenous leukemia 60 years of age and older Am J Med 100 1996 452
14. S. Galimberti, F. Brizzi, M. Mameli, and M. Petrini An Advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection Leuk Res 23 10 October 1999 921 929
15. G. Cervetti, S. Galimberti, and F. Andreazzoli Rituximab as treatment for minimal residual disease in hairy cell leukaemia Eur J Haematol 73 6 December 2004 412 417